Corpus Intelligence IC Memo — MEASE HOSPITAL COUNTRYSIDE 2026-04-26 06:38 UTC
IC Memo — MEASE HOSPITAL COUNTRYSIDE
Investment Committee Memorandum | FL | 375 beds | Grade C | EBITDA uplift $30.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEASE HOSPITAL COUNTRYSIDE

CCN 100265 | PINELLAS, FL | 375 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MEASE HOSPITAL COUNTRYSIDE is a 375-bed suburban community hospital in PINELLAS, FL with $413.1M in net patient revenue and a 11.8% operating margin. The hospital serves a payer mix of 29.5% Medicare, 11.4% Medicaid, and 59.1% commercial.

Thesis: Platform Growth. Our ML models identify $30.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.8% to 19.2% (+736bps).

Net Revenue HCRIS$413.1M
Current EBITDA COMPUTED$48.7M
Operating Margin COMPUTED11.8%
Occupancy HCRIS56.9%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS23.3%
Distress Probability ML48.8%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
96
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 11.8% places it above the state median. Among 96 size-comparable peers (188-750 beds), the median margin is 4.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (188-750), prioritizing same-state peers. 96 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEASE HOSPITAL COUNTRYSIDE (Target)FL375$413.1M11.8%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
MOFFITT CANCER CENTERFL218$1.91B16.0%
LEE MEMORIAL HOSPITALFL748$1.28B17.4%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
ASCENSION SACRED HEART PENSACOFL559$1.04B-10.0%
MOUNT SINAI MEDICAL CENTER OF FL481$904.2M12.2%
TALLAHASSEE MEMORIAL HOSPITALFL483$871.6M-4.8%
SHANDS JACKSONVILLE MEDICAL CEFL481$861.4M-7.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $30.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$8.7M+210bp18mo
Cost to Collect4.5%2.5%$8.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$8.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.0M+122bp9mo
Clean Claim Rate88.0%96.0%$264K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$8.7M
Cost to Collect
$8.3M
Denial Rate Reduction
$8.2M
A/R Days Reduction
$5.0M
Clean Claim Rate
$264K
Total EBITDA Uplift$30.4M
Current EBITDA$48.7M
+ RCM Uplift+$30.4M
Pro Forma EBITDA$79.1M
Current Margin11.8%
Pro Forma Margin19.2%
WC Released (1x)$15.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$75.0M$625.4M8.34x52.8%
Base (11x exit)10.0x11.0x$75.0M$712.3M9.50x56.9%
Bull Case9.0x11.0x$67.5M$837.0M12.41x65.5%
Bull (12x exit)9.0x12.0x$67.5M$933.0M13.83x69.1%
Bear Case11.0x10.0x$82.4M$449.1M5.45x40.4%
Bear (11x exit)11.0x11.0x$82.4M$520.8M6.32x44.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 96 hospitals with 188-750 beds
  • Same-state prioritization (n=97)
  • Comp margins: P25=-4.7% / P50=4.1% / P75=19.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.